Grail, Inc.
Clinical trials sponsored by Grail, Inc., explained in plain language.
-
One blood test for many cancers: can it save lives?
Diagnosis OngoingThis large UK trial is testing whether a new blood test called Galleri can help find cancers at an earlier, more treatable stage. About 140,000 people aged 50-77 are participating. Half will get the test along with their usual NHS care, while the other half will have their blood …
Phase: NA • Sponsor: GRAIL, Inc. • Aim: Diagnosis
Last updated Apr 03, 2026 14:41 UTC
-
Massive study tracks 14,000 people using new cancer blood test
Knowledge-focused OngoingThis study is observing over 14,000 people who have chosen to take the Galleri blood test for early cancer detection in their regular doctor's offices. The goal is to learn how the test performs and is used in real-world medical practice, not in a controlled trial. Researchers wi…
Sponsor: GRAIL, Inc. • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC